Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

1(20%)

Results Posted

50%(1 trials)

Phase Distribution

Ph not_applicable

80%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

N/ANon-phased studies

4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(2)

Other(2)

Detailed Status

unknown2

Completed2

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

recruiting120%

unknown240%

completed240%

Recent Activity

1 active trials

Showing 5 of 5

recruitingnot_applicable

Phenotypic and Genotypic Characterization of Patients With Dysmetabolism in Greenland

NCT06264427

completed

DANish Patients With Atrial Fibrillation and Sleep Apnea Prevalence by Night Owl

NCT04760002

unknownnot_applicable

Clinical Trials (5)

Showing 5 of 5 trials

NCT06264427Not Applicable

Phenotypic and Genotypic Characterization of Patients With Dysmetabolism in Greenland

Recruiting

NCT04760002

DANish Patients With Atrial Fibrillation and Sleep Apnea Prevalence by Night Owl

Completed

NCT04764734Not Applicable

A Validation Study of the NightOwl Home Sleep Apnea Test

Unknown

NCT04191668Not Applicable

A Validation Study of the NightOwl PAT-based Home Sleep Apnea Test

Completed

NCT03774199Not Applicable

NightOwl Pulse Oximeter Calibration Study

Unknown

All 5 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 5